Publication: Malaria community health workers in Myanmar: A cost analysis
Issued Date
2016-01-25
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-84955302740
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.15, No.1 (2016)
Suggested Citation
Shwe Sin Kyaw, Tom Drake, Aung Thi, Myat Phone Kyaw, Thaung Hlaing, Frank M. Smithuis, Lisa J. White, Yoel Lubell Malaria community health workers in Myanmar: A cost analysis. Malaria Journal. Vol.15, No.1 (2016). doi:10.1186/s12936-016-1102-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/40814
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Malaria community health workers in Myanmar: A cost analysis
Abstract
© 2016 Kyaw et al. Background: Myanmar has the highest malaria incidence and attributed mortality in South East Asia with limited healthcare infrastructure to manage this burden. Establishing malaria Community Health Worker (CHW) programmes is one possible strategy to improve access to malaria diagnosis and treatment, particularly in remote areas. Despite considerable donor support for implementing CHW programmes in Myanmar, the cost implications are not well understood. Methods: An ingredients based micro-costing approach was used to develop a model of the annual implementation cost of malaria CHWs in Myanmar. A cost model was constructed based on activity centres comprising of training, patient malaria services, monitoring and supervision, programme management, overheads and incentives. The model takes a provider perspective. Financial data on CHWs programmes were obtained from the 2013 financial reports of the Three Millennium Development Goal fund implementing partners that have been working on malaria control and elimination in Myanmar. Sensitivity and scenario analyses were undertaken to outline parameter uncertainty and explore changes to programme cost for key assumptions. Results: The range of total annual costs for the support of one CHW was US$ 966-2486. The largest driver of CHW cost was monitoring and supervision (31-60 % of annual CHW cost). Other important determinants of cost included programme management (15-28 % of annual CHW cost) and patient services (6-12 % of annual CHW cost). Within patient services, malaria rapid diagnostic tests are the major contributor to cost (64 % of patient service costs). Conclusion: The annual cost of a malaria CHW in Myanmar varies considerably depending on the context and the design of the programme, in particular remoteness and the approach to monitoring and evaluation. The estimates provide information to policy makers and CHW programme planners in Myanmar as well as supporting economic evaluations of their cost-effectiveness.